Stage

Binance Labs: Biotechnology and science require long-term investment, and we are still in the early stages of integrating cryptocurrency technology

ChainCatcher news, Binance Labs stated on the X platform: "During the DeSci Day event held last week at the Binance Labs BUIDLer House in Bangkok, we gathered around 50 like-minded biotech and DeSci enthusiasts to exchange ideas and build connections.In the 3-hour event, speakers shared insights on topics ranging from the development of biotechnology to rapamycin and longevity, citizen science, bioDAO, on-chain intellectual property, and AI agents for science. Some well-known bioDAOs also shared exciting updates—VitaDAO launched their first longevity supplement approved by the Thai FDA. HairDAO is scaling up, applying for a second patent, and launching a shampoo that has significant effects on hair loss. We also invited CZ and Vitalik to interact with the community through an open Q&A session and connect with other DeSci founders and builders.Biotechnology and science are endeavors that require long-term investment, and we are still in the early stages of integrating crypto technology with them. We are excited about the potential and enthusiasm in the biotech field, but we also understand that true innovation requires patience, perseverance, and a long-term vision. We are committed to fostering more innovation in the crypto industry, focusing on lasting achievements and impact. At Binance Labs, we focus on investing in crypto technology, biotechnology, and artificial intelligence. We always pay attention to the core foundation and are dedicated to achieving long-term impact."

RootData: The DeSci track is still in its early stages, with only 2 rounds of funding totaling 11.2 million dollars disclosed this year

ChainCatcher news, recently, Binance founder Zhao Changpeng stated on social media X that he is studying articles related to biotechnology and considering how to leverage cryptocurrency technology to accelerate the flow of research funding. Industry insiders believe that if Zhao Changpeng, who has ample time and resources, enters the DeSci field, it will bring new development opportunities to this sector. Currently, crypto leaders such as Vitalik Buterin and Coinbase founder Brian Armstrong have also expressed strong interest in this field.Overall, the development of the DeSci sector is still in its early stages. According to RootData, the DeSci sector completed $11.2 million in financing in 2024 (as of November), a year-on-year decrease of 18.1%. This year, several financing rounds in this sector include: the DeSci financial layer protocol BIO Protocol completed a $6.2 million public round of financing on August 21 and received strategic investment from Binance Labs on November 8, marking Binance Labs' first investment in the DeSci sector; on September 25, a16z led a $5 million seed round for AminoChain. Additionally, Pfizer had previously invested in VitaDAO in January 2023.In terms of financing scale, the decentralized biotechnology protocol Molecule has raised a total of $13.7 million through three rounds of financing, with over 50 investors including Shine Capital, Northpond Ventures, and Sora Ventures. So far, projects in the DeSci sector have cumulatively raised over $60 million.Data shows that the market capitalization of DeSci project tokens exhibits a clear stratification, with ResearchHub (RSC) leading with a $496 million FDV, followed by HairDAO and VitaDAO with $105 million and $86.83 million, respectively. The second tier is represented by ValleyDAO, GenomeFi, and Data Lake, all with FDVs in the $15-30 million range, but still significantly lower than the leading projects. In September, the Solana ecosystem project Pump.science introduced a meme mechanism for drug research predictions, while the Arweave super parallel computer AO provided new solutions for research data storage; these innovative attempts may drive the development of the DeSci sector.
ChainCatcher Building the Web3 world with innovators